Highway 33 Capital Advisory

Highway 33 Capital Advisory is a private boutique capital advisory firm focused primarily on financing, strategic advisory, and M&A support for companies in highly regulated industries, especially cannabis and hemp. The firm presents itself as active in adjacent sectors such as pharma, biotech, healthcare, AgTech, and ancillary technologies, but its current commercial emphasis appears to be cannabis-sector capital solutions and consulting rather than drug development. Services described on its website include capital raising, mergers and acquisitions advisory, business consulting, licensing and distribution support, and investor introductions. The company appears to operate as an advisory/services business rather than a therapeutics developer, CRO, or CDMO.